Abstract-Intraperitoneal administration of carrageenin-zymosan suspension into rats induced an increment of the free activity and its ratio of aryl sulfatase in the exudate and such was accompanied by protein exudation and polymorphonuclear leukocyte emigration.
Tissue injury resulting from accumulation of phagocytizing granulocytes such as poly morphonuclear (PMN) leukocytes is reported to be a direct consequence of the extracellular discharge of lysosomal constituents (1) (2) (3) (4) . The discharge of lysosomal enzymes is inhibited by certain anti-inflammatory drugs in vitro (5) (6) (7) (8) (9) (10) . In addition, therapeutic treatment of the peritonitic rats with anti-inflammatory drugs such as indomethacin inhibited significantly not only increased vascular permeability and leukocyte emigration, but also elevation of the free activity and its ratio of lysosomal enzymes in the exudate (11) . Recently, 2-{4-(2 imidazo[l,2-a]pyridyl)phenyl} propionic acid (Y-9213) was found by Muro et al to have analgesic, antipyretic and anti-inflammatory activities (12) . This agent also inhibits the discharge of lysosomal enzymes from PMN leukocytes in vitro (13) (14) .
The present investigation was undertaken using the rats with carrageenin-zymosan induced peritonitis to see if Y-9213 could inhibit the in vivo discharge of lysosomal enzymes from PMN leukocytes during phagocytosis of zymosan. The data presented here demon strated that Y-9213 inhibited the release of lysosomal enzymes in vivo at doses showing the anti-inflammatory activities.
MATERIALS AND METHODS

Drugs and preparation of test solution
Y-9213, indomethacin, phenylbutazone and ibuprofen were from yoshitomi Laboratories. * This paper corresponds to "Studies on Anti-inflammatory Agents LI ."
Hydrocortisone, prednisolone and dexamethasone were purchased from Sigma Chemical Co. Ltd. All drugs were suspended in 1 % (v/v) Tween 80-saline.
Animals
Wistar male rats weighing 200-250 g, were used throughout the experiments.
Induction of peritonitis of rats by carrageenin-zymosan
The procedure used here was identical with that reported previously (11) . The rats were injected into the peritoneal cavity with 5.0 ml of 0.025" (w/v) carrageenin (Seakem 402) -0.3 % (w/v) zyrnosan (boiled for 10 min) in sterile saline, killed 5 hr after the injection, and then intraperitoneally injected with 2.0 ml of 100 units/ml of heparin in saline to prevent the coagulation of the exudate. Each test solution or vehicle as controls (10 ml/kg) was orally administered 1 hr before and/or 2 hr after the injection of the carrageenin-zymosan suspension. Immediately after the injection of the heparin solution, the exudates containing PMN leukocytes were carefully collected, kept in ice water, and their volumes were recorded.
The leukocyte counts were performed with a Coulter counter (model ZB) and are shown in the tables as the total number in the collected fluid. The volume of the peritoneal fluid was indicated in the tables as the value without 2 ml of injected heparin solution. Aliquots of the exudates kept in ice water were centrifuged at 1,000 and 27,000 g at 4°C for 10 min. The former supernatant was used to measure the total protein content exuded into the peritoneal cavity by the Biuret reaction (15) . The latter supernatant was used for the measurement of the free activity of lysosomal enzymes. The total activity of these enzymes was assayed using the 27,000 g supernatant obtained by centrifuging the 1.0-nil aliquots of the peritoneal fluid incubated at 37'C for 30 min with 0.1 nil of 2 % (v/v) Triton X-100. Both the free and total activity of lysosomal enzymes were indicated in the tables as tig of p-nitrophenol orp-nitrocatechol formed by the total peritoneal fluid at 37'C for 1 hr unless otherwise stated.
In the preliminary experiment, 2 ml of the heparin solution was injected into the peritoneal cavity of intact rats (N=7).
The peritoneal fluid was 1.8-10.1 ml, when collected carefully from the rat immediately after the injection. Protein contents and leukocyte counts in the collected fluids were 712 mg and 5±1 x 106 cells respectively. In addition, the free and total activity of aryl sulfatase in the fluids were 17±5 and 76-1-15 p g of p-nitrocatechol formed respectively. Therefore, effects of the heparin injection to prevent coagulation of the exudate seem to be negligible on the data obtained in the present experi ments.
Assay of viability of cells
The integrity of the PMN leukocytes was assayed by the method of Zurier et al (16) .
Enzyme assays
Acid phosphatase (EC 3.1.3.2, orthophosphoric monoester phosphohydrolase) and aryl sulfatase (EC 3.1.6.1, aryl sulfate sulfohydrolase) activities were assayed using sodium p-nitrophenyl phosphate and dipotassium p-nitrocatechol sulfate as substrate by the method described previously (17) . (3-Glucuronidase (EC 3.2.1.31, (3-glucuronide glucuronohydrolase) activity was assayed using p-nitrophenyl glucuronide as substrate according to the method of Kato et al (18) . LDH (EC 1.1.1.27, L-lactate: NAD oxidoreductase) activity was deter mined according to the method of Cabaud and Wroblewski (19) .
RESULTS
Effect of Y-9213 on carrageenin-zymosan-induced peritonitis of rats and release of lysosomal enzymes in the exudate Carrageenin-zymosan injected into the peritoneal cavity of rats was able to bring about a remarkable inflammatory reaction which characterized by the protein exudation, leukocyte emigration into the peritoneal cavity and elevation of the free activity of lysosomal enzymes in the peritoneal fluids (Table 1 and Table 2 ). The PMN leukocytes in the exudate, which represent more than 90% of total leukocytes, were viable and contained 2-6 particles/cell. Table I shows the effect of Y-9213 on the inflammatory response in the rat peritonitis. The prophylactic treatment with Y-9213 (treatment B and C in Table 1 ) resulted in the significant inhibition of the increased permeability of protein and leukocyte emigration, and in the decrease of the peritoneal fluid. The therapeutic treatment with Y-9213 (treatment D in Table 1 ) also resulted in the inhibition of the protein exudation, and in the decrease of the peritoneal fluid. In the latter treatment, however, the leukocyte emigration was not inhibited significantly. Table 2 shows the free activity, its ratio to the total activity and the total activity of the marker enzymes in the exudate, and the effect of Y-9213 on them. The ratio of the free activity of the marker enzymes in the exudate obtained 5 hr after the injection of the irritant was 42.7, 38.2 and 16.7 % for aryl sulfatase, 13-glucuronidase and acid phosphatase respec tively. The free activity of LDH, which is not indicated in Table 2 , was 14% of the total activity. On the other hand, in the exudate obtained 5 hr after the injection of the irritant without zymosan particles, the ratio of that of aryl sulfatase was reported to be 10-15 % of the total activity (11) . The increment of the free activity and its ratio of aryl sulfatase and (3-glucuronidase was significantly inhibited by the treatment with Y-9213. On the other hand, the effect of this agent on the release of acid phosphatase was somewhat different as shown in Table 2 . For the enzyme, as the value of both the free and total activity obtained was significantly lower than that in the control (treatment A), no significant differences between any treatments with Y-9213 and the control were observed on the ratio of the free activity of acid phosphatase.
Effects of anti-inif a mmatory drugs on rat peritonitis
The prophylactic effects of Y-9213 and the anti-inflammatory drugs were tested in the treatment C. Table 3 Table 4 eesulted in a dose-related inhibition of the protein exudation and elevation of the free activity and its ratio of aryl sulfatase. Y-9213, indomethacin and phenylbutazone also prevented slightly or significantly the leukocyte emigration into the peritoneal cavity. However, the leukocyte counts were unaffected by dexamethasone, prednisolone and hydro cortisone.
DISCUSSION
The release of injurious constituents from neutrophils during phagocytosis of immune complexes might account for the tissue injury that accompanies the enzyme release (3, 4).
Ammendola et al (20) reported that the activity of lysosomal enzymes parallels the severity of the inflammatory response in carrageenin pleurisy of rats. The treatment of the rats with nonsteroidal anti-inflammatory drugs such as indomethacin and phenylbutazone inhibited both the exudate formation and leukocyte emigration, while failed to reduce the release of lysosomal enzymes into the exudate. The enzyme release from the PMN leukocytes induced by immune complexes resembles that induced by zymosan (21) . In our previous paper (11), the treatment of the carrageenin-induced peritonitis rats with zymosan particles was reported to potentiate not only the increment of the free activity and its ratio of lysosomal enzymes such as acid hydrolase (aryl sulfatase) and neutral protease (SH-protease) in the exudate but also the inflammatory response.
In the present paper, the PMN leukocytes collected from the peritonitis rats are confirmed to be viable and to contain several zymosan particles. Therefore, the increment of the free activity and its ratio of lysosomal enzymes to the total activity in the exudate of the peritonitis rats may be due to the discharge from PMN leukocytes during phagocytosis of the injected particles. The preliminary experiment (Table 1 and Table 2 ) suggests that the prophylactic or therapeutic treatment with Y-9213 results in the inhibition of the in flammatory response and discharge of lysosomal constituents from the emigrated PMN leukocytes. From the data in Table 2 , aryl sulfatase was used as a marker enzyme in the following experiments.
The increment of the free activity and its ratio of aryl sulfatase was inhibited dose dependently by the prophylactic or therapeutic treatment with both steroidal and nonsteroidal anti-inflammatory drugs tested (Table 3 and Table 4 ). The same results were obtained by the treatment with Y-9213. The relative order of their activities is consistent with in vitro data reported previously (14) . The effects of steroidal anti-inflammatory drugs on the inflammatory response seem to be different from those of Y-9213 and nonsteroidal anti inflammatory drugs, which inhibit the leukocyte emigration into the peritoneal cavity in the therapeutic experiments (Table 4 ). These findings suggest that the action of Y-9213 on the inflammatory response may be similar to that of nonsteroidal anti-inflammatory drugs.
The inhibitory effect of Y-9213 on the increment of the free activity and its ratio of aryl sulfatase was less potent than that of indomethacin among the nonsteroidal anti-inflammatory drugs. On the other hand, the acute toxicity (LD50) of Y-9213 in rats was 371 mg/kg, p.o., which was more than 20 times less potent than that of indomethacin. Y-9213 and indomethacin produced the gastrointestinal injury in rats at doses of 25 and 2.5 mg/kg, (p.o.), or more, respectively (unpublished data). Therefore, Y-9213 is better than in domethacin in safety margin.
The inhibitory effect of Y-9213 on the increment of the free activity and its ratio of aryl sulfatase may be due to the inhibition of phagocytosis of the particles or of the discharge of the lysosomal constituents during phagocytosis. Our previous work (14) suggested that Y-9213 fails to inhibit phagocytosis in vitro at concentrations which prevent the enzyme discharge. Therefore, Y-9213 seems to inhibit the discharge of the lysosomal constituents in vivo. In addition, the prevention of the increment of the free activity and its ratio of aryl sulfatase by Y-9213 did accompany the reduction of the protein exudation and volume of the peritoneal fluid. Thus, the inhibition by Y-9213 of the discharge of the lysosomal constituents may be associated with a reduction in the inflammatory response. The mechanism of the inhibitory effect of steroidal anti-inflammatory drugs on the discharge of lysosomal enzymes may be due to the inhibition of the increment of cyclic guanosine mono phosphate concentrations in leukocytes during phagocytosis (8) . The mechanisms of the inhibitory effects of Y-9213 and nonsteroidal anti-inflammatory drugs on the discharge of lysosomal enzymes are still unknown.
The conclusion drawn from these findings is that Y-9213 may elicit anti-inflammatory activities by inhibiting the discharge of lysosomal constituents from PMN leukocytes emigrated into the site of the inflammed lesion.
